DBV Technologies CMO gets options, sells shares

DBV Technologies S.A. reported insider activity by Chief Medical Officer Mohideen Pharis involving new equity awards and small share sales.

Rhea-AI Filing Summary

DBV Technologies S.A. reported insider activity by Chief Medical Officer Mohideen Pharis involving new equity awards and small share sales. On November 21, 2025, he was granted 253,000 stock options with a $2.90 exercise price, expiring November 21, 2035, and 44,000 RSUs, with both awards vesting in four equal annual installments starting November 21, 2026, subject to continued service. He sold a total of 8,120 ordinary shares on November 20–21, 2025 at prices around $2.8800 and $2.7700 per share. After these transactions, he directly holds 145,529 ordinary shares. The company notes that some shares were sold to satisfy withholding tax obligations upon RSU vesting and that each American Depositary Share represents five ordinary shares.

Insider Trade Summary

Net Seller: 8,120 shares

Net Sell 4 txns

Insider Mohideen Pharis

Role Chief Medical Officer

Sold 8,120 shs ($23K)

Type	Security	Shares	Price	Value
Grant/Award	Employee Stock Option (right to buy)	253,000	$0.00	$0.00
Sale	Ordinary Shares	1,624	$2.77	$4K
Grant/Award	Ordinary Shares	44,000	$0.00	$0.00
Sale	Ordinary Shares	6,496	$2.88	$19K

Holdings After Transaction: Employee Stock Option (right to buy) — 253,000 contracts (Direct); Ordinary Shares — 145,529 shares (Direct)

Footnotes (6)

1. F1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.
2. F2. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.
3. F3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15268 to EURO 1.00 as of November 20, 2025.
4. F4. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.
5. F5. Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.
6. F6. The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

Key Figures

Stock options granted: 253,000 options RSUs granted: 44,000 RSUs Total shares sold: 8,120 shares +3 more

6 metrics

Stock options granted 253,000 options Number of employee stock options granted on November 21, 2025 at a $2.90 exercise price, expiring November 21, 2035

RSUs granted 44,000 RSUs Ordinary shares underlying a restricted stock unit award granted November 21, 2025

Total shares sold 8,120 shares Aggregate ordinary shares sold on November 20–21, 2025 by the reporting person

Sale price November 20, 2025 $2.8800 per share Price for sale of 6,496 ordinary shares on November 20, 2025

Sale price November 21, 2025 $2.7700 per share Price for sale of 1,624 ordinary shares on November 21, 2025

Post-transaction holdings 145,529 ordinary shares Directly held ordinary shares after the reported transactions

Key Terms

American Depositary Shares, restricted stock unit ("RSU"), withholding tax obligations, vest in four equal annual installments

4 terms

American Depositary Shares financial

"The ordinary shares may be represented by American Depositary Shares"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

restricted stock unit ("RSU") financial

"Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award"

withholding tax obligations financial

"Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units"

vest in four equal annual installments financial

"The RSUs shall vest in four equal annual installments commencing on November 21, 2026"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did DBVT's Chief Medical Officer Mohideen Pharis receive?

Mohideen Pharis received 253,000 stock options with a $2.90 exercise price expiring November 21, 2035, and 44,000 restricted stock units (RSUs). Both awards vest in four equal annual installments beginning November 21, 2026, contingent on his continued service with DBV Technologies.

How many DBVT shares did Mohideen Pharis sell and at what prices?

Mohideen Pharis sold a total of 8,120 ordinary shares. He sold 6,496 shares at $2.8800 per share on November 20, 2025 and 1,624 shares at $2.7700 per share on November 21, 2025, according to the reported transactions.

How many DBVT shares does Mohideen Pharis own after these transactions?

Following the reported grants and sales, Mohideen Pharis directly holds 145,529 ordinary shares of DBV Technologies. This figure reflects his post-transaction position and does not include unexercised options or unvested RSUs disclosed in the same filing.

What is the vesting schedule for Mohideen Pharis's DBVT RSUs and stock options?

Both the 44,000 RSUs and the 253,000 stock options granted to Mohideen Pharis vest in four equal annual installments. Vesting begins on November 21, 2026, and each installment requires that he continue providing service through the relevant vesting date.

Were any DBVT shares sold by Mohideen Pharis to cover taxes on his awards?

A footnote states that certain shares were sold to satisfy withholding tax obligations upon the vesting of restricted stock units. The filing does not tie this disclosure to a specific transaction row but indicates tax-related sales occurred in connection with RSU vesting.

How do DBV Technologies' American Depositary Shares relate to ordinary shares?

DBV Technologies notes that its ordinary shares may be represented by American Depositary Shares (ADS), with each ADS currently representing five ordinary shares. This ratio helps investors translate between ADS holdings and the underlying ordinary shares reported in insider transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/25/2025 - 04:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mohideen Pharis

(Last) (First) (Middle)

C/O DBV TECHNOLOGIES S.A.

107, AVENUE DE LA REPUBLIQUE

(Street)

CHATILLON I0 92320

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DBV Technologies S.A. [ DBVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares(1)	11/20/2025		S(2)		6,496	D	$2.88(3)	103,153	D
Ordinary Shares(1)	11/21/2025		S(2)		1,624	D	$2.77(4)	101,529	D
Ordinary Shares(1)	11/21/2025		A(5)		44,000	A	$0	145,529	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	$2.9(4)	11/21/2025		A		253,000		(6)	11/21/2035	Ordinary Shares	253,000	$0	253,000	D

Explanation of Responses:

1. The ordinary shares may be represented by American Depositary Shares, each of which currently represents five ordinary shares.

2. Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

3. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15268 to EURO 1.00 as of November 20, 2025.

4. This exercise price is in US Dollars and reflects the conversion of EURO to USD at an exchange rate of $1.15154 to EURO 1.00 as of November 21, 2025.

5. Represents the Issuer's ordinary shares underlying a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one ordinary share. The RSUs shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

6. The option shall vest in four equal annual installments commencing on November 21, 2026, subject to the Reporting Person continuing to provide service through each such date.

	/s/ Virginie Boucinha, Attorney-in-Fact	11/25/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.